Table 3.
Duration of exposure | Dose | Significant side effect | N | Ref. | |
---|---|---|---|---|---|
1 week Treatment, At 1 month monitoring |
Saffron | Crocin | 60 | (15) | |
Tablet/ 200 mg/day, 400 mg/day |
- | None | |||
12 weeks | Capsule/ 30 mg/day | Capsule/ 30 mg/day | Crocin significantly Decreased the FBS Level | 66 | (50) |
12 weeks | Capsule/ 15 mg twice daily | Capsule/ 15 mg twice time a day | WBC count increased significantly in patients receiving saffron, but it was within the normal range | 66 | (51) |
One month | - | Tablet/ 20 mg | Significant decreased in amylase, mixed white blood cells and PTT | 42 | (37) |
1 week | Tablet/ 200 mg/day, 400 mg/day | - | At dose of 400 mg: significant decrease in standing systolic blood pressure, mean arterial pressures, RBC and increase in Na+, BUN and creatinine | 30 | (36) |
At dose of 200 mg: Decrease in RBC, Hb, HCT, PLT, INR, bleeding time and increase in creatinine |